In vitro antimicrobial activity of eight new beta-lactam antibiotics against penicillin-resistant Neisseria gonorrhoeae.

Antimicrobial Agents and Chemotherapy
S B KerbsW O Harrison

Abstract

Increasing numbers of cases of penicillin-resistant gonorrhea necessitate the evaluation of new antibiotics for treatment of this disease. We tested the susceptibility of 92 penicillinase-producing (PP) Neisseria gonorrhoeae isolates and 88 penicillin-susceptible (PS) isolates to eight new beta-lactam antibiotics. The minimal inhibitory concentrations of these antibiotics were determined by the agar plate method. PP and PS N. gonorrhoeae isolates were susceptible to clinically achievable levels of all antibiotics tested. There were, however, marked differences among the drugs with regard to the concentration required to inhibit growth. The PP N. gonorrhoeae isolates were extremely susceptible to ceftriaxone, ceftizoxime, and cefotaxime, highly susceptible to moxalactam and cefoperazone, and less susceptible to cefoxitin, ceforanide, and cefonicid (geometric mean minimal inhibitory concentrations were 0.002, 0.003, 0.007, 0.03, 0.07, 0.6, 2.4, and 3.1 micrograms/ml, respectively). Although this in vitro study showed PP N. gonorrhoeae isolates to be comparatively more susceptible to ceftriaxone, ceftizoxime, and cefotaxime than to the other antibiotics, these results may not correlate with clinical efficacy.

References

Sep 25, 1976·Lancet·W A AshfordV G Hemming
Nov 1, 1979·Antimicrobial Agents and Chemotherapy·K P FuH C Neu
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Jun 1, 1981·The British Journal of Venereal Diseases·E H SngK L Yeo
Mar 1, 1981·Antimicrobial Agents and Chemotherapy·T C Eickhoff, J Ehret
Sep 1, 1981·Antimicrobial Agents and Chemotherapy·H C Neu, S Srinivasan
Apr 1, 1981·Antimicrobial Agents and Chemotherapy·W M ScheldM A Sande
Aug 1, 1980·Antimicrobial Agents and Chemotherapy·T T YoshikawaP A Oill
Apr 1, 1981·Antimicrobial Agents and Chemotherapy·L de Repentigny, P L Turgeon
Dec 1, 1980·Antimicrobial Agents and Chemotherapy·P AngehrnR L Then
Mar 1, 1981·Antimicrobial Agents and Chemotherapy·H C NeuK P Fu
Feb 1, 1982·Antimicrobial Agents and Chemotherapy·S RipaM Pfeffer
Nov 1, 1981·Clinical Pharmacology and Therapeutics·D PitkinR Stote

❮ Previous
Next ❯

Citations

Oct 1, 1983·European Journal of Clinical Microbiology·W M Scheld
Oct 1, 1993·Diagnostic Microbiology and Infectious Disease·M S BarrettM E Erwin
Jan 1, 1991·International Journal of Antimicrobial Agents·H H Gadebusch, D L Shungu
Jul 19, 1984·The New England Journal of Medicine·S R CriderS W Berg
Sep 1, 1985·Antimicrobial Agents and Chemotherapy·W S NgP C Wong
Jun 26, 1987·The American Journal of Medicine·L G KaplowitzR P Gruninger
Nov 1, 1996·Memórias do Instituto Oswaldo Cruz·M C de CastilloA P de Ruiz Holgado

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.